26Indexed trials
mesh condition
Epilepsies, Myoclonic
Intelligence
Epilepsies, Myoclonic intelligence: 26 indexed trials, 8 recruiting studies, 19 sponsors across 27 countries.
8Recruiting
19Sponsors
27Countries
Leading sponsors
Jazz Pharmaceuticals41 recruiting
Encoded Therapeutics32 recruiting
Gillette Children's Specialty Healthcare20 recruiting
Ionis Pharmaceuticals, Inc.21 recruiting
Epygenix11 recruiting
Fondation Ophtalmologique Adolphe de Rothschild10 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10 recruiting
Longboard Pharmaceuticals10 recruiting
Loulou Foundation11 recruiting
NYU Langone Health10 recruiting
Takeda10 recruiting
UCB BIOSCIENCES, Inc.10 recruiting
Geographic activity
United States18trials
Italy8trials
Spain7trials
United Kingdom6trials
Australia6trials
France5trials
Canada5trials
Germany4trials
Poland3trials
Brazil3trials
China2trials
Belgium2trials
Leading interventions
Cannabidiol3trials
ETX1012trials
GWP42003-P2trials
Clemizole HCl1trials
Epidiolex 100 mg/mL Oral Solution1trials
Fenfluramine Hydrochloride1trials
GWP42003-P 10 mg/kg/day Dose1trials
GWP42003-P 20 mg/kg/day Dose1trials
GWP42003-P 5 mg/kg/day Dose1trials
ION3371trials
LP3521trials
Lorcaserin1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.